Search reports.
Clinical Trials Support Services Market Size | Forecast 2031
Get free sample report Request for Customiztion Buy Now

Clinical Trials Support Services Market Size | Forecast 2031

Segments - Clinical Trials Support Services Market by Phases (Phase I, Phase II, Phase III, and Phase IV) and Regions (North America, Europe, Asia Pacific, Middle-East & Africa, and Latin America) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3843 | 4.2 Rating | 84 Reviews | 223 Pages | Format : PDF Excel PPT

Report Description


The clinical trials support services market size was valued at USD 20.8 billion in 2022 and is expected to surpass USD 39.88 billion by 2031, expanding at a CAGR of 7.5% during the forecast period, 2023–2031. The growth of the market is attributed to increasing demand in expanding economies, high R&D investment, rising number of CROs.

A clinical trial is a prospective study in humans that compares the effect and value of intervention(s) versus a control. Clinical trial support services are a collection of services used by pharmaceutical firms during clinical studies for the approval of novel drug molecules or the entry of generics and biosimilars into the market. Four phases are involved in clinical trials for research investigation.

Clinical Trials Support Services Market Outlook

Phase I conducted to measure the human pharmacology, safety, to know maximum pharmacology, and tolerability of drug. Phase II is conducted to check the pharmacovigilance, toxicity, tolerability, and efficacy of drug. Phase III is generated additional data on safety & efficacy, and phase IV is conducted to provide details about safety & efficacy.

  • Rising frequency of infectious and tropical illnesses in the area, there are significant unmet clinical trial requirements in emerging countries which boost the market.

  • Due to numerous patent expiration the research and development need in pharmaceutical companies is increasing to develop new molecule for survival.

  • Growing number of CROs and disease prevalence is projected to boost the market.

  • In certain countries, there is an insufficient regulatory framework for conducting clinical trials this is estimated to hamper the market.

  • Requirement of strict patient enrollment in clinical trials is projected to restrain the market growth.

Scope of the Report

The report on the clinical trials support services market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Clinical Trials Support Services Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Phase (Phase I, Phase II, Phase III and Phase IV)

Geographic Scope

North America, Europe, Asia-Pacific, Middle-East & Africa, and Latin America

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Charles River Laboratories, Inc.; Eurofins Scientific.; Laboratory Corporation of America Holdings (Covance Inc.).; Alcura Health.; PPD Inc.

Market Segment Insights

The phase I segment is expected to grow at a rapid pace

On the basis of phases, the clinical trials support services market is divided into phase I, phase II, phase III, and phase IV. The phase I segment is expected to grow at a rapid pace during the forecast period. Despite the outsourcing trend, developing countries only host a small percentage of phase I studies.

As a result of the aforementioned factors, as well as rising healthcare spending, an increasing number of Investigational New Drug (IND) applications filed, and the trend of outsourcing, the drug development process is projected to drive the market. Phase III segment dominated the market in 2020. The segment rise is fueled by the fact that phase III studies are the most expensive and involve a significant number of participants. Hence, there is an increasing demand for the phase III component.

Clinical Trials Support Services Market Phase

North America dominated the market in 2020

In terms of regions, the clinical trials support services market is classified North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. North America dominated the market in 2020 and held 50.6% of the total share due to increasing number of pharmaceutical firms based in the United States to conduct most of their business in this region.

Major drivers of the market are rising R&D spending and increasing demand for medication development. The market in Asia Pacific is estimated to expand at a rapid pace during forecast period. Growth of the regional market is attributed to simplicity of administrative compliance, developing patient population, and presence of major players in the region.

Clinical Trials Support Services Market Region

Segments

The clinical trials support services market has been segmented on the basis of

Phase

  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Geography

  • North America
  • Europe
  • Asia-Pacific
  • Middle-East & Africa
  • Latin America

Key Players

Competitive Landscape

Some of the key market players competing in the clinical trials support services market are Charles River Laboratories, Inc.; Eurofins Scientific.; Laboratory Corporation of America Holdings (Covance Inc.).; Alcura Health.; PPD Inc.

Some of these players are using several market strategies such as acquisitions, merger, collaborations, partnerships, capacity expansion, and product launches to enhance their market shares and to generate revenue and raise their production line of the business in the coming years.

Clinical Trials Support Services Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Trials Support Services Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Clinical Trials Support Services Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Clinical Trials Support Services Market - Supply Chain
  4.5. Global Clinical Trials Support Services Market Forecast
     4.5.1. Clinical Trials Support Services Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Clinical Trials Support Services Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Clinical Trials Support Services Market Absolute $ Opportunity
5. Global Clinical Trials Support Services Market Analysis and Forecast by Region
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Region
     5.2.2. Y-o-Y Growth Projections by Region
  5.3. Clinical Trials Support Services Market Size and Volume Forecast by Region
     5.3.1. North America
     5.3.2. Latin America
     5.3.3. Europe
     5.3.4. Asia Pacific
     5.3.5. Middle East and Africa (MEA)
  5.4. Absolute $ Opportunity Assessment by Region
  5.5. Market Attractiveness/Growth Potential Analysis by Region
  5.6. Global Clinical Trials Support Services Demand Share Forecast, 2019-2026
6. North America Clinical Trials Support Services Market Analysis and Forecast
  6.1. Introduction
     6.1.1. Basis Point Share (BPS) Analysis by Country
     6.1.2. Y-o-Y Growth Projections by Country
  6.2. North America Clinical Trials Support Services Market Size and Volume Forecast by Country
     6.2.1. U.S.
     6.2.2. Canada
  6.3. Absolute $ Opportunity Assessment by Country
  6.4. Market Attractiveness/Growth Potential Analysis
     6.4.1. By Country
     6.4.2. By Product Type
     6.4.3. By Application
  6.5. North America Clinical Trials Support Services Demand Share Forecast, 2019-2026
7. Latin America Clinical Trials Support Services Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
     7.1.3. Latin America Average Pricing Analysis
  7.2. Latin America Clinical Trials Support Services Market Size and Volume Forecast by Country
      7.2.1. Brazil
      7.2.2. Mexico
      7.2.3. Rest of Latin America
   7.3. Absolute $ Opportunity Assessment by Country
  7.4. Market Attractiveness/Growth Potential Analysis
     7.4.1. By Country
     7.4.2. By Product Type
     7.4.3. By Application
  7.5. Latin America Clinical Trials Support Services Demand Share Forecast, 2019-2026
8. Europe Clinical Trials Support Services Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Europe Average Pricing Analysis
  8.2. Europe Clinical Trials Support Services Market Size and Volume Forecast by Country
     8.2.1. Germany
     8.2.2. France
     8.2.3. Italy
     8.2.4. U.K.
     8.2.5. Spain
     8.2.6. Russia
     8.2.7. Rest of Europe
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. Market Attractiveness/Growth Potential Analysis
     8.4.1. By Country
     8.4.2. By Product Type
     8.4.3. By Application
  8.5. Europe Clinical Trials Support Services Demand Share Forecast, 2019-2026
9. Asia Pacific Clinical Trials Support Services Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Asia Pacific Average Pricing Analysis
  9.2. Asia Pacific Clinical Trials Support Services Market Size and Volume Forecast by Country
     9.2.1. China
     9.2.2. Japan
     9.2.3. South Korea
     9.2.4. India
     9.2.5. Australia
     9.2.6. Rest of Asia Pacific (APAC)
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Market Attractiveness/Growth Potential Analysis
     9.4.1. By Country
     9.4.2. By Product Type
     9.4.3. By Application
  9.5. Asia Pacific Clinical Trials Support Services Demand Share Forecast, 2019-2026
10. Middle East & Africa Clinical Trials Support Services Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Middle East & Africa Average Pricing Analysis
  10.2. Middle East & Africa Clinical Trials Support Services Market Size and Volume Forecast by Country
     10.2.1. Saudi Arabia
     10.2.2. South Africa
     10.2.3. UAE
     10.2.4. Rest of Middle East & Africa (MEA)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Market Attractiveness/Growth Potential Analysis
     10.4.1. By Country
     10.4.2. By Product Type
     10.4.3. By Application
  10.5. Middle East & Africa Clinical Trials Support Services Demand Share Forecast, 2019-2026
11. Competition Landscape
  11.1. Global Clinical Trials Support Services Market: Market Share Analysis
  11.2. Clinical Trials Support Services Distributors and Customers
  11.3. Clinical Trials Support Services Market: Competitive Dashboard
  11.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     11.4.1. Charles River Laboratories, Inc.
     11.4.2. Eurofins Scientific.
     11.4.3. Laboratory Corporation of America Holdings (Covance Inc.)
     11.4.4. Alcura Health
     11.4.5. PPD Inc.

Methodology

Our Clients

sinopec
General Electric
Nestle SA
Siemens Healthcare
Honda Motor Co. Ltd.
FedEx Logistics
Deloitte
General Mills